Amedisys Inc (AMED)

Working capital turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 2,348,324 2,321,060 2,289,626 2,251,407 2,236,382 2,227,658 2,229,409 2,234,331 2,223,199 2,220,452 2,215,949 2,222,225 2,214,112 2,205,500 2,196,085 2,116,978 2,071,519 2,021,492 1,972,053 1,979,978
Total current assets US$ in thousands 632,083 579,947 555,902 526,448 496,935 467,227 426,544 405,557 388,961 388,780 394,869 392,485 356,684 432,882 390,965 380,450 361,984 411,250 449,540 468,128
Total current liabilities US$ in thousands 514,392 486,021 479,976 484,860 473,721 468,119 462,401 353,050 355,529 367,200 427,372 380,154 374,282 454,349 449,223 456,082 456,337 437,496 442,048 316,106
Working capital turnover 19.95 24.71 30.16 54.14 96.34 42.55 66.50 102.89 180.21 263.22 13.02

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $2,348,324K ÷ ($632,083K – $514,392K)
= 19.95

The working capital turnover ratio for Amedisys Inc indicates how efficiently the company is utilizing its working capital to generate revenue. The working capital turnover is calculated by dividing revenue by the average working capital during a certain period.

The trend analysis of Amedisys Inc's working capital turnover reveals fluctuations over the past few years.

In March 2020, the working capital turnover was 13.02, which increased significantly to 263.22 by June 2020. The sharp rise in the ratio may indicate a more efficient use of working capital to generate revenue during that period.

However, from September 2020 to December 2023, the working capital turnover ratio was not available (denoted by '—'), which could suggest incomplete data or changes in financial reporting practices.

In March 2022, the working capital turnover ratio was 180.21, showing a strong ability to generate revenue utilizing working capital. This was followed by a decrease in efficiency as the ratio dropped to 30.16 by June 2024.

The trend reflects fluctuating efficiencies in using working capital to generate revenue, and further analysis would be needed to understand the reasons behind these variations and their impact on the company's overall financial performance.


Peer comparison

Dec 31, 2024